Clover Health Investments, Corp. (CLOV)
NASDAQ • Healthcare
Last close at October 26, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Clover Health Investments, Corp. keeps $4 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 4
in 8 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Clover Health Investments’ revenue topped consensus in the second fiscal quarter of 2026, reported August 5, 2026, as revenue rose 56% to roughly $743 million (up from about $478 million a year ago) and came in at $743.2 million versus a $728.3 million estimate (+2%, topped), reflecting growth in its Medicare-focused insurance business across PPO and HMO plan offerings. Profitability tracked with that higher volume, with gross profit of about $153 million and gross margin at roughly 21%. The company generated operating cash flow of about $25 million for the quarter. For the next period, consensus calls for EPS of -$0.00 on revenue of $738.2 million.
Next report — what to expect
Clover Health Investments, Corp. is set to report earnings on November 3, 2026. Wall Street expects EPS of -$0.01 on revenue of $740.3 million. For trailing context, revenue grew +55.6% year over year last quarter. CLOV has beaten EPS in 4 of its 8 most recent quarters.
About Clover Health Investments, Corp.
Clover Health Investments, Corp. offers healthcare insurance on the NASDAQ Global Select under ticker CLOV, serving Medicare-eligible members through Preferred Provider Organization (PPO) health plans and Health Maintenance Organization (HMO) health plans. In FY2025, it generated $1.9 billion in revenue.
Today's Snapshot
CLOV closed 0.9% below yesterday's close, while its sector was flat. Clover Health interim CFO Clay Thornton will present at the UBS Global Healthcare Conference on November 9. CLOV reports earnings on 4 November.
Trading Volume
Below 10d avg (3.4M)
2.4M
vs S&P 500 Today
Underperforming Market
-1.56%
Updated: October 26, 2026 at 20:22 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$3.62 - $4.64Buy
- RSI (14)48.74Neutral
- Stochastic %K (14, 3, 3)36.26Neutral
- MACD Level (12, 26)0.04Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.